LISA CASTLES: Open Payments
NPI 1588760201 · LAKE CITY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,727 in 94 payments from 24 companies in 2025. Trend: 2023 $1,442 · 2024 $1,556 · 2025 $1,727
Food & beverage: $1,727
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $303 |
| Novo Nordisk Inc | 9 | $270 |
| AstraZeneca Pharmaceuticals LP | 16 | $249 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $147 |
| ABBVIE INC. | 6 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $92 |
| Amgen Inc. | 5 | $91 |
| GlaxoSmithKline, LLC. | 5 | $79 |
| Esperion Therapeutics, Inc. | 3 | $66 |
| PFIZER INC. | 3 | $50 |
Products named: CAPLYTA, Ozempic, Kerendia, FARXIGA, JARDIANCE, OTEZLA, AIRSUPRA, VRAYLAR.
Industry payments across SC — which companies pay providers there.
